Childrens Chewable Acetaminophen Tablet, Chewable
NDC Package 57896-148-03
Package Information
Childrens Chewable Acetaminophen (acetaminophen) tablets is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a tablet, chewable delivery system. Marketed by Geri-care Pharmaceutical Corp, this product is identified by NDC 57896-148 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 307696 - acetaminophen 80 MG Chewable Tablet
- RxCUI: 307696 - APAP 80 MG Chewable Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 57896 - Geri-care Pharmaceutical Corp
- 57896-148 - Childrens Chewable Acetaminophen
- 57896-148-03 - 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 57896-148 - Childrens Chewable Acetaminophen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57896-148-03 identifies a specific commercial package of 30 tablet, chewable in 1 bottle, plastic of Childrens Chewable Acetaminophen, a human over the counter drug labeled by Geri-care Pharmaceutical Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, chewable is formulated for oral use and contains acetaminophen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Geri-care Pharmaceutical Corp on February 01, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this Geri-care Pharmaceutical Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57896014803. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.